Researchers unlock mechanism of drug resistance in aggressive breast cancer
January 27, 2017
ºÚÁÏÍø Lineberger researchers find how triple negative breast cancer cells are able to bypass treatment with trametinib, an FDA-approved drug. The researchers also used lab models of breast cancer to test a potential treatment approach that could prevent resistance.